Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.
about
Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastasesMedical management of brain tumors and the sequelae of treatment.Advances in treatment of brain metastases from primary non-small cell lung cancerMeningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO reviewPhase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis.TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.Orthotopic models of pediatric brain tumors in zebrafishMonitoring and optimising cognitive function in cancer patients: Present knowledge and future directions.Neuropsychological assessment of individuals with brain tumor: comparison of approaches used in the classification of impairment.Leptomeningeal metastases: a RANO proposal for response criteria.Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study.Neurocognitive functioning and genetic variation in patients with primary brain tumours.Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study.The Rationale for Targeted Therapies and Stereotactic Radiosurgery in the Treatment of Brain Metastases.Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?Oral Targeted Therapies and Central Nervous System (CNS) Metastases.Mechanisms of radiotherapy-associated cognitive disability in patients with brain tumours.Melanoma central nervous system metastases: current approaches, challenges, and opportunities.Assessment of Brain Tumor Response: RANO and Its Offspring.Updates in the management of brain metastases.Angiogenesis inhibitors in tackling recurrent glioblastoma.Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer.Factors Affecting the Baseline and Post-Treatment Scores on the Hopkins Verbal Learning Test-Revised Japanese Version before and after Whole-Brain Radiation Therapy.The value of 4-month neurocognitive function as an endpoint in brain metastases trials.Response Assessment in Neuro-Oncology Clinical Trials.The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.Imaging and clinical end points in brain metastases trials.4π plan optimization for cortical-sparing brain radiotherapy.Prophylactic Cranial Irradiation in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
P2860
Q26768667-61CA1DC7-52AC-4146-8603-2DE82FFA172EQ26992174-2B57FE31-0133-4D70-A97A-50753B54024AQ27022452-6B60BF1E-2B6A-42DA-8A2F-60770F0A8E43Q30356126-B8B4EB22-3ED5-47B9-94ED-AF3152C67770Q33438666-8BD3CB8D-6BDD-4CB7-893D-AC428543E6C1Q33891408-9C5767C6-B1A9-4557-9610-F8A09B695382Q33954557-F816CD28-3429-461B-9011-D7612DF6FE90Q34381550-A5675817-17EB-45C8-8090-94112B283A40Q34604438-2B9452B6-B766-417F-9722-B03795D59950Q35166810-AFBAFAEA-1FD6-4E89-BBAF-0C8E70BA3D37Q36236770-939965D3-3AEE-46F0-B1C1-EE09BF8A80C1Q36618258-C542625A-1627-464F-AD39-704C1131C3A9Q37561807-31F68BE8-93E1-4333-9DD3-2E492C3F1A32Q37601465-F1A13895-402B-4E7F-A673-21187B2441ADQ38289478-2506D751-E035-4F6C-961D-709A37894C5EQ38551397-68DCB3FA-CC3F-4605-B68F-B9F0C6E48800Q38631975-E354A512-E071-426E-9C2C-B3DF4085DF62Q38782122-F6A2237B-B5C7-459E-82F7-051999DAF6A1Q38807942-53015CA6-59EC-4835-9403-765AF2AD14FAQ38855020-DA7D8108-ADCD-4038-95AA-DC1E14E95E1CQ38887451-56A4760A-7C38-4A09-A77F-8062205B44D6Q39259089-D23CBF39-921E-4174-AAEA-38BE75779D92Q40308252-F419E904-A03E-4FBD-942C-04B35EE8237DQ40482799-D5B4C6AD-B3C5-4517-BA13-AF9D796EDA9DQ44325965-C553BA75-B707-4809-AAA1-33792EE195D3Q45945655-811C09C0-1C1F-453D-9342-AD439A1A397FQ46085094-4066B890-1B34-480E-83A8-96C70ED9EAA3Q47772412-941CF6C7-76D9-4CD2-835D-73F272183349Q48031513-B6CC1B63-345C-4E64-90AF-84DA43DC7A29Q51742654-9591A8FB-FF57-4716-A413-12A43142AC0AQ54974208-4F492B02-4D09-47B9-A73B-8092E0487DFC
P2860
Challenges relating to solid tumour brain metastases in clinical trials, part 2: neurocognitive, neurological, and quality-of-life outcomes. A report from the RANO group.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Challenges relating to solid t ...... A report from the RANO group.
@en
type
label
Challenges relating to solid t ...... A report from the RANO group.
@en
prefLabel
Challenges relating to solid t ...... A report from the RANO group.
@en
P2093
P1433
P1476
Challenges relating to solid t ...... . A report from the RANO group
@en
P2093
Brigitta G Baumert
D Ross Camidge
David R Macdonald
David Schiff
Eudocia Q Lee
F Stephen Hodi
Hidefumi Aoyama
Igor J Barani
Janet Dancey
Jeffrey S Wefel
P304
P356
10.1016/S1470-2045(13)70308-5
P577
2013-09-01T00:00:00Z